Mitsui & Company makes strategic investment in Avon Organics’ parent company

17 Jan 2013 Evaluate

Japan based Mitsui & Company has made a strategic investment in Avon Organics’ parent company - Arch Pharmalabs (Arch) through a secondary market transaction, whereby the Japanese company has purchased 27.29% equity capital of Arch from private equity investors.

The transaction has been completed on January 16, 2013. Subsequent to which Mitsui & Company’s shareholding in Arch has increased from 4.67% to 31.96%.

Arch presently hold 63.60% equity capital of Avon Organics thereby making it a subsidiary company. However, there is no change envisaged/contemplated in the control and management of Arch Pharmalabs and/or at Avon Organics, pursuant to strategic investment by Mistui & Company in Arch.

Kobo Biotech Share Price

2.23 -0.08 (-3.46%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×